Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called “Systematic evolution of ligands by exponential enrichment” (SELEX).
The global aptamers market is poised for rapid growth between 2018 and 2025. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market.

Market Analysis and Insights: Global Aptamers Market
The global Aptamers market is valued at US$ 56 million in 2019. The market size will reach US$ 128.3 million by the end of 2026, growing at a CAGR of 12.5% during 2021-2026.

Global Aptamers Scope and Market Size
Aptamers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aptamers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers

Segment by Application
Research and Development
Drug Discovery

By Company
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia